Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity

Berrill, J. W., Green, John, Hood, Kerenza and Campbell, Anthony Keith 2013. Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity. Alimentary Pharmacology and Therapeutics 38 (1) , pp. 44-51. 10.1111/apt.12335

Full text not available from this repository.

Abstract

Background: Symptoms compatible with irritable bowel syndrome (IBS) are frequently present in patients with inflammatory bowel disease (IBD); however, the cause of this phenomenon is unclear. Aim: To determine the different contributions of ‘true IBS’ and sub-clinical inflammation in producing IBS-type symptoms in IBD patients, and to ascertain the impact these symptoms have on the clinical assessment of IBD activity. Methods: In this cross-sectional study, 169 IBD patients completed questionnaires to assess disease activity, presence of IBS-type symptoms, and levels of anxiety and depression. Stool samples were collected for analysis of faecal calprotectin (FC). Results: IBS-type symptoms were significantly more common in female patients (OR = 4.64, 1.55–13.88) and were associated with higher levels of anxiety (OR = 1.11, 1.01–1.21). There was no statistical difference between the FC levels of patients in clinical remission with IBS-type symptoms compared with those without (median values = 111 μg/g vs. 45.5 μg/g respectively, P = 0.171). The prevalence of IBS-type symptoms in patients with a normal FC level was 31%. Conclusions A substantial number of IBD patients with normal faecal calprotectin level experience IBS-type symptoms. These patients exhibit similar features to people diagnosed with IBS in the general community, suggesting that the conditions are not mutually exclusive and may coexist in a considerable number of IBD patients. A systematic diagnostic approach is required to assess IBD patients with IBS-type symptoms as sub-clinical inflammation may play a role in a proportion of cases.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Pharmacy
Subjects: R Medicine > RC Internal medicine
R Medicine > RS Pharmacy and materia medica
R Medicine > RZ Other systems of medicine
Uncontrolled Keywords: Adult; Anxiety; Cross-Sectional Studies; Depression; Disease Progression; Female; Humans; Inflammation; Inflammatory Bowel Diseases; Irritable Bowel Syndrome; Male; Middle Aged; Questionnaires; Severity of Illness Index
Publisher: Wiley-Blackwell
ISSN: 0269-2813
Last Modified: 14 Sep 2017 10:48
URI: http://orca.cf.ac.uk/id/eprint/65523

Citation Data

Cited 47 times in Scopus. View in Scopus. Powered By Scopus® Data

Cited 19 times in Web of Science. View in Web of Science.

Actions (repository staff only)

Edit Item Edit Item